We serve Chemical Name:Dipropyleneglycol methyl ether acetate CAS:88917-22-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:Dipropyleneglycol methyl ether acetate
CAS.NO:88917-22-0
Synonyms:1-[(1-Methoxy-2-propanyl)oxy]-2-propanyl acetate;UNII:5455FZE9RB;MFCD00144160;Di(propylene glycol) methyl ether acetate;2-Propanol, 1-(2-methoxy-1-methylethoxy)-, acetate;DPMA
Molecular Formula:C9H18O4
Molecular Weight:190.237
HS Code:2942000000
Physical and Chemical Properties:
Melting point:N/A
Boiling point:229.8±15.0 °C at 760 mmHg
Density:1.0±0.1 g/cm3
Index of Refraction:1.418
PSA:44.76000
Exact Mass:190.120514
LogP:0.25
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:NA 1993 / PGIII
Packing Group:
Contact us for information like 1-[(1-Methoxy-2-propanyl)oxy]-2-propanyl acetate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,DPMA physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Di(propylene glycol) methyl ether acetate Use and application,MFCD00144160 technical grade,usp/ep/jp grade.
Related News: Darzalex has its own VRd combo trials, dubbed PERSEUS and CEPHEUS, which are testing a newly approved under-the-skin version of the J&J drug called Darzalex Faspro. The CEPHEUS trial appears to have just completed its primary analysis, according to a listing on ClinicalTrials.gov. Dipropyleneglycol methyl ether acetate manufacturer The pharmaceutical industry is related to the national economy and the people’s livelihood. The entire upstream and downstream areas involve all aspects of the national economy. Our government has a long-term direct or indirect policy preference for this. Dipropyleneglycol methyl ether acetate supplier Darzalex has its own VRd combo trials, dubbed PERSEUS and CEPHEUS, which are testing a newly approved under-the-skin version of the J&J drug called Darzalex Faspro. The CEPHEUS trial appears to have just completed its primary analysis, according to a listing on ClinicalTrials.gov. Dipropyleneglycol methyl ether acetate vendor Lilly did show much more conclusively that donanemab, which zeroes in on amyloid plaques, does reduce levels of the aggregates of misfolded proteins in the brain. This is what Biogen also showed with Aduhelm, and it turned out this week to be enough for a full FDA approval, hence the stock bump for Lilly. Dipropyleneglycol methyl ether acetate factory In the current trial, a total of 196 patients were randomly chosen to receive either the vaccine or a placebo.
